The purpose of the company is to leverage quantum biology, artificial intelligence and multiomics to revolutionize drug discovery. The goal is to develop a proprietary platform that integrates multiomics, imaging and real-world patient data to enable precise target identification, in-silico validation and quantum-informed drug design. The aim is to accelerate therapy development and improve clinical success rates.
Commercial register, canton of ZH·As of May 19, 2026View on Zefix
Comparisons
Elixion BioTech AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Elixion BioTech AG by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.